In February 2022, the Indian pharmaceutical company Cadila Healthcare saw its cardiac drug segment grow at a seven percent. The company's cardiac drug formulation, Lipaglyn followed suite at a growth rate of a little over 63 percent and its cardiac drug Atorva therapy grew at two percent that year.
Growth rate of therapy drugs manufactured by Cadila Healthcare in India in February 2022
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Motilal Oswal Group. (March 8, 2022). Growth rate of therapy drugs manufactured by Cadila Healthcare in India in February 2022 [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/1096955/india-cadila-healthcare-therapy-drugs-growth-rate/
Motilal Oswal Group. "Growth rate of therapy drugs manufactured by Cadila Healthcare in India in February 2022." Chart. March 8, 2022. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1096955/india-cadila-healthcare-therapy-drugs-growth-rate/
Motilal Oswal Group. (2022). Growth rate of therapy drugs manufactured by Cadila Healthcare in India in February 2022. Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1096955/india-cadila-healthcare-therapy-drugs-growth-rate/
Motilal Oswal Group. "Growth Rate of Therapy Drugs Manufactured by Cadila Healthcare in India in February 2022." Statista, Statista Inc., 8 Mar 2022, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1096955/india-cadila-healthcare-therapy-drugs-growth-rate/
Motilal Oswal Group, Growth rate of therapy drugs manufactured by Cadila Healthcare in India in February 2022 Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1096955/india-cadila-healthcare-therapy-drugs-growth-rate/ (last visited November 10, 2024)
Growth rate of therapy drugs manufactured by Cadila Healthcare in India in February 2022 [Graph], Motilal Oswal Group, March 8, 2022. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/1096955/india-cadila-healthcare-therapy-drugs-growth-rate/
